AAAAAA
Results:
1-7
|
Results: 7
Authors:
Ben-Chetrit, A
Eldar-Geva, T
Gal, M
Huerta, M
Mimon, T
Algur, N
Diamant, YZ
Margalioth, EJ
Citation: A. Ben-chetrit et al., The questionable use of albumin for the prevention of ovarian hyperstimulation syndrome in an IVF programme: a randomized placebo-controlled trial, HUM REPR, 16(9), 2001, pp. 1880-1884
Authors:
Eldar-Geva, T
Robertson, DM
Cahir, N
Groome, N
Gabbe, MP
Maclachlan, V
Healy, DL
Citation: T. Eldar-geva et al., Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone, J CLIN END, 85(2), 2000, pp. 607-613
Authors:
Eldar-Geva, T
Wood, C
Lolatgis, N
Rombauts, L
Kovacs, G
Fuscaldo, J
Trounson, AO
Citation: T. Eldar-geva et al., Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction, HUM REPR, 14(6), 1999, pp. 1461-1466
Authors:
Out, HJ
Lindenberg, S
Mikkelsen, AL
Eldar-Geva, T
Healy, DL
Leader, A
Rodriguez-Escudero, FJ
Garcia-Velasco, JA
Pellicer, A
Citation: Hj. Out et al., A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon (R)) in women undergoing ovarian stimulation, HUM REPR, 14(3), 1999, pp. 622-627
Authors:
Gal, M
Eldar-Geva, T
Margalioth, EJ
Barr, I
Orly, J
Diamant, YZ
Citation: M. Gal et al., Attenuation of ovarian response by low-dose ketoconazole during superovulation in patients with polycystic ovary syndrome, FERT STERIL, 72(1), 1999, pp. 26-31
Authors:
Eldar-Geva, T
Citation: T. Eldar-geva, Preovulatory rise in progesterone, HUM REPR, 13(9), 1998, pp. 2658-2658
Authors:
Eldar-Geva, T
Lowe, PJM
MacLachlan, V
Rombauts, L
Healy, DL
Citation: T. Eldar-geva et al., Different influence of incongruent follicular development on in vitro fertilization-embryo transfer and gamete intrafallopian transfer pregnancy rates, FERT STERIL, 70(6), 1998, pp. 1039-1043
Risultati:
1-7
|